{"id":"azithromycin-1-gram","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"},{"rate":"5-10%","effect":"Abdominal pain"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This action prevents the formation of peptide bonds, ultimately inhibiting bacterial growth and replication. Azithromycin is a macrolide antibiotic that is effective against a wide range of Gram-positive and Gram-negative bacteria.","oneSentence":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:57:52.993Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Community-acquired pneumonia"},{"name":"Acute bacterial sinusitis"},{"name":"Pharyngitis/tonsillitis"}]},"trialDetails":[{"nctId":"NCT03909737","phase":"PHASE4","title":"Oral Azithromycin to Prevent Stillbirths and Infant Mortality in Mali","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2020-09-24","conditions":"Stillbirths and Infant Mortality","enrollment":99700},{"nctId":"NCT07183462","phase":"PHASE4","title":"Azithromycin and Ampicillin for Late PPROM","status":"RECRUITING","sponsor":"Sheba Medical Center","startDate":"2025-09-10","conditions":"Pregnancy Complications, Infectious, Premature Birth, Neonatal Diseases and Abnormalities","enrollment":311},{"nctId":"NCT06468462","phase":"PHASE4","title":"Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-29","conditions":"Gonorrhea Male, Chlamydia (Male), Syphilis Male","enrollment":2900},{"nctId":"NCT06418711","phase":"PHASE3","title":"ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension","status":"TERMINATED","sponsor":"Mannkind Corporation","startDate":"2024-09-11","conditions":"MAC Lung Disease, Treatment Refractory MAC Lung Disease, Mycobacterium Infections, Nontuberculous","enrollment":132},{"nctId":"NCT03953118","phase":"PHASE4","title":"Azithromycin for Meibomian Gland Disease","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2019-09-01","conditions":"Dry Eye, Neuropathic Eye Pain, Ocular Microbiome","enrollment":2},{"nctId":"NCT04326478","phase":"PHASE2","title":"Single Dose Azithromycin to Prevent Cholera in Children","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-10-31","conditions":"Cholera","enrollment":920},{"nctId":"NCT03801252","phase":"EARLY_PHASE1","title":"Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term","status":"COMPLETED","sponsor":"University of Oklahoma","startDate":"2018-12-12","conditions":"Obesity, Induction of Labor Affected Fetus / Newborn","enrollment":186},{"nctId":"NCT05132829","phase":"PHASE4","title":"Azithromycin to Improve Latency in Exam Indicated Cerclage Control Trial","status":"UNKNOWN","sponsor":"Thomas Jefferson University","startDate":"2021-12-20","conditions":"Preterm Birth, Obstetric Labor, Premature, Obstetric Labor Complications","enrollment":50},{"nctId":"NCT04012177","phase":"NA","title":"Nutritional Support and Prophylaxis Doses of Azithromycin for Pregnant Women - Mumta Pregnant Women Trial","status":"UNKNOWN","sponsor":"Vital Pakistan Trust","startDate":"2019-07-22","conditions":"Undernutrition","enrollment":1884},{"nctId":"NCT03248297","phase":"PHASE4","title":"Antibiotic Prophlaxis for High-risk Laboring Women in Low Income Countries","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2018-01-12","conditions":"Postpartum Sepsis, Postpartum Endometritis, Postpartum Fever","enrollment":756},{"nctId":"NCT03474276","phase":"PHASE3","title":"Comparing Several Strategies to Manage Moderate Acute Malnutrition Among Children From 6 to 24 Months Old","status":"COMPLETED","sponsor":"Institut Pasteur","startDate":"2018-01-31","conditions":"Moderate Acute Malnutrition","enrollment":1357},{"nctId":"NCT03079388","phase":"NA","title":"Nutritional and Anti-infective Interventions for Malnutrition in Pregnancy (Beleuman Welbodi)","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2017-02-27","conditions":"Pregnancy, Malnutrition in Pregnancy, Nutrition Disorders","enrollment":1489},{"nctId":"NCT03608774","phase":"PHASE4","title":"Trial of Azithromycin vs. Doxycycline for the Treatment of Rectal Chlamydia in MSM","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-07-13","conditions":"Anal Chlamydia Infection","enrollment":177},{"nctId":"NCT04395768","phase":"PHASE2","title":"International ALLIANCE Study of Therapies to Prevent Progression of COVID-19","status":"UNKNOWN","sponsor":"National Institute of Integrative Medicine, Australia","startDate":"2020-09-09","conditions":"COVID19","enrollment":200},{"nctId":"NCT03386227","phase":"NA","title":"Prophylactic Antibiotics Prior to Embryo Transfer (PAPET): RCT","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2018-01-21","conditions":"Assisted Reproductive Technology, Antibiotic Prophylaxis, Embryo Transfer","enrollment":96},{"nctId":"NCT00322465","phase":"PHASE2","title":"NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2006-11","conditions":"Urethritis","enrollment":305},{"nctId":"NCT02344628","phase":"PHASE3","title":"Comparison of Two Different Doses of Azithromycin for Treatment of Yaws","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2015-06","conditions":"Yaws","enrollment":583},{"nctId":"NCT00035347","phase":"PHASE4","title":"Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-01","conditions":"Community-Acquired Pneumonia (CAP)","enrollment":219},{"nctId":"NCT02176057","phase":"PHASE2, PHASE3","title":"Nepal Elimination of Trachoma Study","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2014-08","conditions":"Trachoma","enrollment":""},{"nctId":"NCT01072136","phase":"PHASE3","title":"Empiric Therapy of Mucopurulent Cervicitis (MPC)","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2010-03","conditions":"Vaginitis Bacterial, Cervicitis","enrollment":87},{"nctId":"NCT00031499","phase":"PHASE3","title":"Azithromycin/Bicillin Syphilis","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2000-06","conditions":"Syphilis","enrollment":593},{"nctId":"NCT01631201","phase":"PHASE2","title":"Safety and Efficacy Study of Rifalazil for the Treatment of Chlamydia Trachomatis Infection in Women","status":"COMPLETED","sponsor":"ActivBiotics Pharma, LLC","startDate":"2012-07","conditions":"Chlamydia Trachomatis Infection","enrollment":82},{"nctId":"NCT00644176","phase":"PHASE2","title":"A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery","status":"COMPLETED","sponsor":"Pfizer","startDate":"2004-11","conditions":"Pharmacokinetics","enrollment":66},{"nctId":"NCT00153634","phase":"NA","title":"Standard vs. Biofilm Susceptibility Testing in Cystic Fibrosis (CF)","status":"COMPLETED","sponsor":"Seattle Children's Hospital","startDate":"2004-03","conditions":"Cystic Fibrosis, Chronic Bronchitis","enrollment":75}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Zithromax"],"phase":"phase_2","status":"active","brandName":"Azithromycin 1 gram","genericName":"Azithromycin 1 gram","companyName":"ActivBiotics Pharma, LLC","companyId":"activbiotics-pharma-llc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Azithromycin inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. Used for Community-acquired pneumonia, Acute bacterial sinusitis, Pharyngitis/tonsillitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}